Takeda Pharmaceutical Co Ltd (TAK)

TheFly reported on June 23 that TAK announced positive topline findings from its Phase 3 LATITUDE Atlas study evaluating zasocitinib, an investigational oral TYK2 inhibitor, in adults with moderate-to...

Investors looking for large returns without making a sizable initial commitment are still drawn to low-priced companies.

TheFly reported on May 18 that a federal jury in the U.S. District Court for the District of Massachusetts determined that Takeda Pharmaceutical Company violated U.S.

Despite growing geopolitical tensions related to the Iran war, Callanish Capital CEO Haig Bathgate shared an optimistic stance on global markets during an appearance on CNCB on May 7.

Takeda Pharmaceutical Company Limited (NYSE:TAK) Q4 2026 Earnings Call Transcript May 13, 2026Takeda Pharmaceutical Company Limited beats earnings expectations.

Japanese equities have held steady amid heightened volatility in global markets. The country’s main equity index, the Nikkei 225, has gained 15% year to date, dwarfing the 4% gain for the S&P 500.

Pullbacks tend to create favorable setups when they hit more than just the weakest parts of the market.

On March 25, Scott Chronert of Citi joined 'Closing Bell' on CNBC to discuss whether it is time to enter the market and if recent presidential actions have changed the market dynamic.

Takeda Pharmaceutical Company Limited (NYSE:TAK) is one of the most promising stocks under $20.